Home » Geopolitics » U.S. Buying $290M Worth of Anti-Radiation Drugs for Use in ‘Nuclear Emergency’

Olduvai
Click on image to purchase

Olduvai III: Catacylsm
Click on image to purchase

Post categories

Post Archives by Category

U.S. Buying $290M Worth of Anti-Radiation Drugs for Use in ‘Nuclear Emergency’

U.S. Buying $290M Worth of Anti-Radiation Drugs for Use in ‘Nuclear Emergency’


The Biden regime is buying up $290 million in anti-radiation drugs for use in “nuclear emergencies” amid escalating tensions with Russia and heightened threats of a nuclear war.


From Health and Human Services:

FOR IMMEDIATE RELEASE
October 4, 2022

Contact HHS Press Office
202-821-9446
asprmedia@hhs.gov
www.hhs.gov/news
Twitter: @HHSgov

HHS purchases drug for use in radiological and nuclear emergencies

As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).

Amgen, based in Thousands Oaks, California, developed Nplate for ARS with support from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR), as well as the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

BARDA is using its authority provided under the 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug. Amgen will maintain this supply in vendor-managed inventory. This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.

ARS, also known as radiation sickness, occurs when a person’s entire body is exposed to a high dose of penetrating radiation, reaching internal organs in a matter of seconds. Symptoms of ARS injuries include impaired blood clotting as a result of low platelet counts, which can lead to uncontrolled and life-threatening bleeding.

…click on the above link to read the rest of the article…

Olduvai IV: Courage
In progress...

Olduvai II: Exodus
Click on image to purchase

Click on image to purchase @ FriesenPress